PROSTAGLANDINS & OTHER LIPID MEDIATORS, published by Elsevier Science Inc, is a leading journal dedicated to the advancements in the field of lipid mediators, with a specific focus on prostaglandins and other bioactive lipids. This journal, indexed under ISSN 1098-8823 and E-ISSN 2212-196X, serves as a crucial platform for researchers and professionals to disseminate significant findings that span multiple disciplines, including Biochemistry, Cell Biology, Pharmacology, and Physiology. In the 2023 category quartiles, it has achieved commendable positions such as Q2 in Biochemistry and Q2 in Physiology, underscoring its importance and influence in these domains. Although it is not an open-access journal, it provides robust access options, enhancing the visibility of vital research. With its establishment in 1996, the journal continues its commitment to fostering innovative research until 2024, making it an essential resource for those involved in the dynamic realms of lipid biology and medical research.

BIOLOGICHESKIE MEMBRANY is a critical journal in the field of Cell Biology and Molecular Biology, published by MEZHDUNARODNAYA KNIGA in the Russian Federation. With an ISSN of 0233-4755, this journal has been serving the academic community since 1996 and continues to publish cutting-edge research that advances our understanding of biological membranes and their functions. Despite being classified in Q4 quartiles for both Cell and Molecular Biology in the 2023 category rankings, the journal presents a unique platform for emerging research within these pivotal areas. Researchers, professionals, and students alike will find valuable insights in its pages as it seeks to foster a collaborative environment that encourages knowledge sharing. Although currently not available as an open-access journal, it remains an essential resource for those looking to deepen their knowledge and contribute to ongoing discussions in the biological sciences. The journal’s commitment to publishing quality research is underscored by its continuous coverage until 2024, making it a sustained reference in the field.

Algal Research - Biomass Biofuels and Bioproducts is a prestigious academic journal published by Elsevier, dedicated to advancing the field of algal biotechnology and its applications in biomass, biofuels, and bioproducts. With an ISSN of 2211-9264 and a notable impact factor, this journal is recognized as a leading source of innovative research, boasting a current Scopus rank of #31 out of 406 in the domain of Agricultural and Biological Sciences, specifically Agronomy and Crop Science, positioning it in the top 8% of its field (92nd percentile). This open-access publication, established in 2012 and covering literature up to 2024, prioritizes disseminating high-quality research that fosters sustainable solutions for energy and bioproducts derived from algal resources. As a Q1 ranked journal in the 2023 Agronomy and Crop Science category, it serves as a vital resource for researchers, professionals, and students seeking to understand and leverage the potential of algae within the biodiverse framework of bioeconomy and sustainable practices.

JOURNAL OF CELL SCIENCE, with ISSN 0021-9533 and E-ISSN 1477-9137, is a distinguished publication in the field of Cell Biology, released by COMPANY BIOLOGISTS LTD in the United Kingdom. Since its inception in 1966, this journal has served as a vital platform for disseminating cutting-edge research and reviews that significantly advance our understanding of cellular processes and innovations. Currently positioned in the Q1 category within the 2023 rankings, this journal is recognized for its high impact and quality, holding a notable Scopus rank of 120 out of 285 in the Cell Biology category, placing it within the 58th percentile. While not an open-access journal, it provides extensive access options for readers and institutions, ensuring that pivotal research is accessible to a wide audience. With converged publication years leading toward 2024, JOURNAL OF CELL SCIENCE continues to be an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of the intricate workings of cell biology.

PPAR Research, an esteemed journal published by HINDAWI LTD, specializes in the rapidly evolving fields of drug discovery and pharmacology, contributing significantly to the body of research surrounding peroxisome proliferator-activated receptors (PPARs) and their roles in various biochemical processes. With an open access policy implemented since 2006, the journal ensures that its high-quality content is readily available, promoting widespread dissemination of knowledge. Currently ranked in the Q2 category for both Drug Discovery and Medical Pharmacology, it boasts a respectable position within the scientific community, evidenced by its Scopus rankings. PPAR Research serves as an essential resource for researchers, professionals, and students looking to advance their understanding of PPAR biology and its implications in therapeutic development. The journal's commitment to excellence and accessibility makes it a key player in supporting innovative research and critical discussions in the life sciences.

Molecular Metabolism is a premier, open-access journal published by Elsevier, dedicated to advancing the understanding of metabolic processes at the molecular level. With an ISSN of 2212-8778 and a proud presence in Germany, the journal has made significant contributions to the fields of Cell Biology and Molecular Biology, consistently achieving a Q1 ranking in both categories as of 2023. The journal’s scope encompasses cutting-edge research that explores metabolic pathways, their regulation, and implications for human health, underscoring the interplay between metabolism and various biological functions. Researchers and professionals benefit from the journal’s robust visibility, as it ranks #40 among 410 journals in Molecular Biology and #35 among 285 in Cell Biology according to Scopus metrics, placing it in the top 10 percentile in its field. With open access since 2012, Molecular Metabolism ensures that groundbreaking research is available to all, fostering a collaborative and inclusive academic environment. Its commitment to excellence and accessibility makes it an invaluable resource for those invested in metabolic research.

LIPIDS is a renowned peer-reviewed journal published by Wiley, dedicated to the field of lipid research, encompassing biochemistry, molecular biology, and organic chemistry. With its roots dating back to 1966 and a commitment to advancing knowledge until 2024, this journal serves as a vital platform for sharing significant findings in lipid biochemistry and its applications in health and disease. Although it currently does not offer Open Access options, it maintains a respectable standing with a Q3 ranking in Biochemistry and Organic Chemistry, and a Q4 ranking in Cell Biology based on the 2023 category quartiles. Additionally, its Scopus rankings reflect a solid position within the organic chemistry and biochemistry subfields. Published from Germany, LIPIDS caters to researchers, professionals, and students eager to explore the roles of lipids in biological processes and innovatory applications in various scientific disciplines.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to the study of bioenergetics and biomembranes, covering essential topics such as cellular energy transformation and membrane dynamics. Since its inception in 1976, the journal has developed a robust reputation within the scientific community, currently holding a Q3 ranking in Cell Biology and a Q2 ranking in Physiology for 2023. Boasting a prestigious Scopus Rank in both Biochemistry and Physiology, it serves as a crucial platform for disseminating pioneering research findings. With its commitment to quality and innovation, the journal plays a significant role in advancing our understanding of the fundamental processes that underlie life at the cellular level. Although it does not offer open access options, the journal remains accessible through universities and research institutions, ensuring that vital research is widely shared among scholars, professionals, and students alike. The JOURNAL OF BIOENERGETICS AND BIOMEMBRANES is essential for anyone seeking to contribute to or stay informed about developments in this dynamic field.

Progress in Lipid Research, published by Pergamon-Elsevier Science Ltd, is a leading scientific journal dedicated to advancing the understanding of lipid biology and its implications for human health. With an impressive impact factor, it ranks in the Q1 quartile in both Biochemistry and Cell Biology as of 2023, reflecting its vital role in disseminating high-quality research. Covering a wide scope of topics from lipid metabolism to cell signaling pathways, the journal serves as a key resource for researchers, professionals, and students alike, striving to elucidate the complex functions of lipids in various biological systems. With publication converging since 1978 and extending to 2024, Progress in Lipid Research continues to provide innovative insights and foster collaboration within the scientific community, solidifying its reputation as an essential platform for lipid research.